Category Archives: Peptides

Inaugural Insights for Clinical Success: Top Lessons From The A4M Weight Management Certification Program

Inaugural Insights for Clinical Success: Top Lessons From The A4M Weight Management Certification Program

Earlier this month, the first class of pioneering soon-to-be weight management experts gathered for the inaugural Clinical Weight Management Certification Program in Scottsdale, Arizona. This immersive experience was filled with insightful lectures, thought-provoking discussions, and engaging collaborative learning opportunities that left participants empowered and equipped with the critical knowledge and skills needed to navigate the complex weight management landscape. Amid the current obesity epidemic and craze surrounding Ozempic and similar “miracle” weight loss drugs, acquiring expertise in this field has become increasingly vital for healthcare providers across disciplines.

Renowned faculty members took the stage — including specialty leaders Ben Gonzaléz, MD, Gordon Crozier, DO, and James LaValle, RPh, CCN, MT — sharing their wealth of knowledge and presenting a practical, integrative approach to weight management. Drawing from their extensive experience as leaders in the functional and integrative weight management revolution, they provided attendees with easily applicable tools and protocols designed to achieve sustainable, long-term results for their patients.

Newly minted certification holders raved about the Clinical Weight Management Certification Program, citing its timeliness, relevance, esteemed faculty, and comprehensive scope as the primary reasons for their satisfaction. They praised the course’s ability to bridge the gap between the latest research and clinical application, providing a solid foundation for success in the ever-evolving field of weight management.

For those unable to attend, we’re delighted to offer a sneak peek into the transformative education this certification provides — before its second iteration occurs October 24-25 in Boston, MA.

Continue reading

Live From Miami Beach: A4M March Symposium Highlights 

Reporting live from Miami Beach, A4M is hosting hundreds of modern medicine’s leading game-changers this weekend at the March Symposium. We’re thrilled to be amongst such an inspiring crowd of renowned experts, pioneering researchers, and dedicated practitioners committed to elevating their knowledge, practice, and patient outcomes — a thriving community we are honored to be a part of.

This highly anticipated event marks the kickoff of A4M’s 2024 educational season — and it’s set to be groundbreaking. Featuring beloved returning programs and brand-new courses alike, the weekend’s diverse agenda empowers practitioners across every specialty and sector to level up their clinical toolkits and gain practical knowledge of emerging and in-demand therapeutic modalities.

From the best-selling BHRT Symposium to the inaugural iteration of State Of-Mind: A New Era in Psychedelic Medicine – a three-day immersive training in pioneering psychedelic-assisted therapies, transformative insights, and clinical pearls abound.

If you couldn’t join us this time, we want to ensure you don’t miss out on the wealth of cutting-edge learning taking place. Since we cannot teleport you to the Loews Miami Beach Hotel — although we wish we could — our on-site team has been sharing real-time updates for us to relay. Discover some key takeaways and event highlights from all the offerings on the agenda.

Continue reading

Mapping The Longevity Blueprint: Peptide Therapies

“The current use of peptides is everything you can think of. From antimicrobial, antioxidant, and anti-obesity uses, to hormone regulation, dyslipidemia, digestion, and cognitive performance enhancement. Virtually every bodily function you can think of utilizes peptides.” James LaValle, RPh, CCN, MT, DHM, DHPh, A4M Scientific Planning Committee and IPS Steering Committee Chair 

The mapping of the human longevity blueprint has launched a new era of research into peptide therapies for precision life extension. Groundbreaking peptide advances welcome a coming age in which the root causes of aging may be targeted, optimized, and potentially reversed – expanding the boundaries of the human lifespan. This paradigm shift represents a transition from reactive to proactive aging management, addressing fundamental age-related decline rather than downstream effects alone.

Today, there are over 90 FDA-approved peptide therapeutics with over 150 in clinical development and up to 600 undergoing preclinical trials. In medical practices across the globe, peptide therapies are being used to help treat cancer, infectious diseases, metabolic disorders, injuries, and much more.

Research continues to unveil the power of peptide therapies for disease management, performance optimization, and longevity strategies.

Continue reading